Imrecoxib

DB12354InvestigationalSmall molecule

Imrecoxib has been used in trials studying the treatment of Knee Osteoarthritis.

Chemical structure of Imrecoxib
Formula / weight
C21H23NO3S · 369.48 g/mol (avg)
Code names
BAP-909

Resolves to

Compound
UNIISGW6W5758VCAS395683-14-4ChEMBLCHEMBL504535PubChem11682175
Structure
InChIKeyAXMZZGKKZDJGAZ-UHFFFAOYSA-NSMILESCCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O
Targets
P35354PTGS2P23219PTGS1

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Imrecoxib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In